MARKET

TLRY

TLRY

TILRAY, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.900
-0.465
-8.67%
Opening 13:23 09/23 EDT
OPEN
5.14
PREV CLOSE
5.37
HIGH
5.20
LOW
4.850
VOLUME
7.95M
TURNOVER
--
52 WEEK HIGH
29.50
52 WEEK LOW
2.430
MARKET CAP
623.17M
P/E (TTM)
-1.0380
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Sept. 23, 2020: JNJ, LULU, PTON, KSS, TLRY
Today's 5 Stock Ideas:  Johnson & Johnson (JNJ) - Shares were up 2% Wednesday morning following news the company initiated a Phase 3 trial for Janssen Pharma's COVID-19 vaccine
Benzinga · 4h ago
Aurora Cannabis down 10% on soft revenue outlook
It's the first earnings report for Aurora (ACB) since Miguel Martin was named as the new CEO on September 8. For 2020 FQ4, the company lost $1.9B; for all of
Seekingalpha · 19h ago
Marijuana Stocks: Aurora Cannabis Earnings Due As New CEO Steps In
Investor's Business Daily · 22h ago
Compass Pathways Takes Investors on a Trip to Higher Prices
Fresh off IPO, Compass sees mushrooming opportunity in psilocybin....CMPS
TheStreet.com · 1d ago
Jefferies Upgrades Aurora And Tilray, Says Valuations, Estimates 'Now More Realistic'
Cannabis stocks Tilray Inc. (NASDAQ: TLRY) and Aurora Cannabis Inc. (NYSE: ACB) traded lower on Monday amid a broad market sell-off. One Wall Street analyst upgraded the two stocks and said they may finally be priced at a level that accurately reflects their true value.The Analyst: On Monday, Jefferies
Benzinga · 1d ago
MJ: Yes, The Marijuana ETF Has Provided A Steady 6-7% Yield
With the Fed aiming to keep rates near zero for at least the next few years, income seekers will need to venture out on the risk spectrum for higher yields.One pretty unconventional sector that could help fill the income gap is marijuana.The fund's largest underlying components don't pay a dividend, but securities lending allows MJ to pay a 6%+ yield.I'll examine MJ one more time to review the income generation process and discuss its place within an income portfolio.
Seekingalpha · 1d ago
Aurora Cannabis and Tilray Have Fallen a Lot This Year. Why the Stocks May Be Steady for Now.
Aurora and Tilray have cut costs this year but both companies have other headwinds, one analyst says.
Barrons.com · 2d ago
Implied Volatility Surging for Tilray (TLRY) Stock Options
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Zacks · 2d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TLRY. Analyze the recent business situations of TILRAY, INC. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TLRY stock price target is 8.15 with a high estimate of 15.00 and a low estimate of 0.0000.
EPS
Institutional Holdings
Institutions: 286
Institutional Holdings: 14.47M
% Owned: 11.38%
Shares Outstanding: 127.18M
TypeInstitutionsShares
Increased
52
3.89M
New
82
76.29K
Decreased
18
631.92K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.55%
Pharmaceuticals & Medical Research
+0.12%
Key Executives
President/Chief Executive Officer/Director
Brendan Kennedy
Chief Financial Officer
Michael Kruteck
Corporate Executive
Katy Dickson
Chief Operating Officer
Jon Levin
Other
Edward Pastorius
Other
Andrew Pucher
Independent Director
Michael Auerbach
Independent Director
Christine Clare
Independent Director
Michael ..
Independent Director
Rebekah Dopp
Independent Director
Maryscott Greenwood
Independent Director
Soren Schroder
Independent Director
Christine St.Clare
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About TLRY
Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Tilray Inc stock information, including NASDAQ:TLRY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLRY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TLRY stock methods without spending real money on the virtual paper trading platform.